Multivalent RGD synthetic peptides as potent αVβ3 integrin ligands

被引：76

作者：

Garanger, E

Boturyn, D

Coll, JL

Favrot, MC

Dumy, P

机构：

[1] Univ Grenoble 1, CNRS, LEDSS, UMR 5616, F-38041 Grenoble 9, France

[2] Inst Albert Bonniot, INSERM, U578, Grp Rech Canc Poumon, F-38706 La Tronche, France

来源：

ORGANIC & BIOMOLECULAR CHEMISTRY | 2006年 / 4卷 / 10期

关键词：

D O I：

10.1039/b517706e

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

We study herein the multivalency effect of a cluster of alpha(v)beta(3)-ligands held on a cyclodecapeptide template. An array of RAFT(c[-RGDfK-])(n) derivatives containing from one to sixteen clustered RGD motifs were synthesized and comparatively assayed in vitro on alpha(v)beta(3)-expressing cells. Efficient inhibition of the alpha(v)beta(3)-specific 23C6 monoclonal antibody fixation was observed with ligands displaying three and four copies of the cyclo[-RGDfK-] peptide.

引用

收藏

页码：1958 / 1965

页数：8

相关论文

共 33 条

[1] Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis [J].

Boturyn, D ;

Coll, JL ;

Garanger, E ;

Favrot, MC ;

Dumy, P .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (18) :5730-5739

[2] A convenient access to αVβ3/αVβ5 integrin ligand conjugates:: regioselective solid-phase functionalisation of an RGD based peptide [J].

Boturyn, D ;

Dumy, P .

TETRAHEDRON LETTERS, 2001, 42 (15) :2787-2790

[3] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].

BROOKS, PC ;

MONTGOMERY, AMP ;

ROSENFELD, M ;

REISFELD, RA ;

HU, TH ;

KLIER, G ;

CHERESH, DA .

CELL, 1994, 79 (07) :1157-1164

[4] RGD peptides and monoclonal antibodies, antagonists of αv-integrin, enter the cells by independent endocytic pathways [J].

Castel, S ;

Pagan, R ;

Mitjans, F ;

Piulats, J ;

Goodman, S ;

Jonczyk, A ;

Huber, F ;

Vilaró, S ;

Reina, M .

LABORATORY INVESTIGATION, 2001, 81 (12) :1615-1626

[5] N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists [J].

Dechantsreiter, MA ;

Planker, E ;

Mathä, B ;

Lohof, E ;

Hölzemann, G ;

Jonczyk, A ;

Goodman, SL ;

Kessler, H .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (16) :3033-3040

[6] A CONVENIENT SYNTHESIS OF CYCLIC-PEPTIDES AS REGIOSELECTIVELY ADDRESSABLE FUNCTIONALIZED TEMPLATES (RAFT) [J].

DUMY, P ;

EGGLESTON, IM ;

CERVIGNI, S ;

SILA, U ;

SUN, X ;

MUTTER, M .

TETRAHEDRON LETTERS, 1995, 36 (08) :1255-1258

[7]

Forget D, 2001, CHEM-EUR J, V7, P3976, DOI 10.1002/1521-3765(20010917)7:18<3976::AID-CHEM3976>3.0.CO

[8]

2-X

[9] New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors [J].

Garanger, E ;

Boturyn, D ;

Jin, ZH ;

Dumy, P ;

Favrot, MC ;

Coll, JL .

MOLECULAR THERAPY, 2005, 12 (06) :1168-1175

[10] Influencing receptor-ligand binding mechanisms with multivalent ligand architecture [J].

Gestwicki, JE ;

Cairo, CW ;

Strong, LE ;

Oetjen, KA ;

Kiessling, LL .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (50) :14922-14933

← 1 2 3 4 →